Data security risks are growing as more and more clinical trials embrace telemedicine and other digital technologies. The challenge is the complexity of securing a clinical trial ecosystem that may involve hundreds of data input points, trial sites, networks and applications, including patient’s own devices.
Wearables, smart phone apps, telemedicine platforms, and remote testing kits (for blood, for example), are just a few examples.
“We’re seeing increased use of technology and technology partners. When you think about the entire, end-to-end data flow through the many clinical trial partners, you have to consider the Internet of Things (IoT) and data that is flowing from a lot of different devices,” Doug Shaw, CISA, principal consultant, the Halloran Consulting Group, told BioSpace.
